6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: China SXT Pharmaceuticals, Inc.
Filed: January 31, 2022
Period of Report: January 31, 2022
Accession Number: 0001213900-22-004496

View Document ↗ View on SEC.gov ↗